Crossmark

Real world outcomes and prognostic factors in Chinese patients with primary mediastinal B cell lymphoma: A single center experience and the Surveillance, Epidemiology, and End Results validation

Crossref DOI link: https://doi.org/10.1007/s00277-026-06914-4

Published Online: 2026-02-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Boya

Chen, Ruize

Wang, Huanhuan

Qiu, Tonglu

Liang, Zihan

Cao, Lei

Zhu, Huayuan

Xu, Wei

Fan, Lei

Li, Jianyong

Miao, Yi

Xia, Yi
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82170186, 82370193, 81720108002)

National Natural Science Foundation of China (82170186, 82370193, 81720108002)

Jiangsu Province Capability Improvement Project through Science, Technology and Education (ZDXK202209)

Jiangsu Province Capability Improvement Project through Science, Technology and Education (ZDXK202209)

China Postdoctoral Science Foundation (2021M691336)

Postdoctoral Science Foundation of Jiangsu Province (2021K083A)
License Information

Text and Data Mining valid from 2026-02-28

Version of Record valid from 2026-02-28
More Information

Article History

Received: 14 December 2025

Accepted: 18 February 2026

First Online: 28 February 2026

Declarations

:

: All authors read and approved the manuscript as submitted.

: The authors declare no competing interests.

: No previously published material was reproduced in this manuscript.

: Patients were not included in any clinical trial.

: This study was proved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University and performed in accordance with the Declaration of Helsinki.

: All patients had given written informed consent for collection and use of data.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below